Gene · 151306
Papers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Obesity, Nutrition and the Multiple Sclerosis Risk in Adolescents. | Brain Sci | 2026 | 41892626 | PubTator, text mining | PubMed |
| Potential far-reaching metabolic consequences of cholecystectomy. | Eur J Clin Invest | 2026 | 41888988 | PubTator, text mining | PubMed |
| The microbiota-gut-brain axis in Huntington's disease: Evidence, mechanisms and therapeutic opportunities. | Front Neuroendocrinol | 2026 | 41876029 | PubTator, text mining | PubMed |
| Impact of Pesticide Use on Gut Microbiota and Health: A Systematic Review of Findings in Both Humans and Animal Models. | J Xenobiot | 2026 | 41874112 | PubTator, text mining | PubMed |
| Hepato-ocular crosstalk: Bile acids bridging pathogenesis and therapy. | iScience | 2026 | 41852735 | PubTator, text mining | PubMed |
| A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis. | Gut Microbes | 2026 | 41851067 | PubTator, text mining | PubMed |
| A review on molecular crosstalk: Bioactive polysaccharides and gut microbiota in type 2 diabetes-Pathways, signaling, and therapeutic translation. | Int J Biol Macromol | 2026 | 41850461 | PubTator, text mining | PubMed |
| Plasma sterol profiling in autism spectrum disorder: insights from cerebrotendinous xanthomatosis screening and beyond. | Metab Brain Dis | 2026 | 41848945 | PubTator, text mining | PubMed |
| Antibiotic overuse as a modifiable early-life risk factor for non-communicable diseases in sub-Saharan Africa. | Glob Health Action | 2026 | 41848103 | PubTator, text mining | PubMed |
| Targeting the gut-kidney axis to improve kidney transplantation prognosis: from mechanisms to clinical intervention strategies. | Ren Fail | 2026 | 41845903 | PubTator, text mining | PubMed |
| The role of microbiota derived metabolites in modulating diabetic inflammation: a systematic review. | J Mol Histol | 2026 | 41843212 | PubTator, text mining | PubMed |
| Bidirectional Crosstalk Between Intestinal Epithelium and Immune Microenvironment in Inflammatory Bowel Disease: Mechanisms and Therapeutic Implications. | J Inflamm Res | 2026 | 41835113 | PubTator, text mining | PubMed |
| Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host. | Gut Microbes | 2026 | 41830551 | PubTator, text mining | PubMed |
| An Update on Bile Acid-Regulated Signalling in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease. | Liver Int | 2026 | 41811003 | PubTator, text mining | PubMed |
| Remodeling the Inflammatory Microenvironment: Nanomaterial-Based Targeted Strategies for Systemic Lupus Erythematosus and Lupus Nephritis. | Small Sci | 2026 | 41810047 | PubTator, text mining | PubMed |
| Health and environmental evidence, challenges, and sustainable strategies of Planetary Health Diet: A mixed-methods review. | Eco Environ Health | 2026 | 41810019 | PubTator, text mining | PubMed |
| The gut-retina axis in age-related macular degeneration: immune crosstalk and metabolite production. | Exp Biol Med (Maywood) | 2026 | 41809655 | PubTator, text mining | PubMed |
| Ileal bile acid transporter inhibitors for chronic constipation in the elderly. | World J Gastrointest Pharmacol Ther | 2026 | 41809226 | PubTator, text mining | PubMed |
| Microbiota metabolite lithocholic acid in cancer: Mechanisms and therapeutic potential. | Exp Cell Res | 2026 | 41802534 | PubTator, text mining | PubMed |
| Multi-site microbiota crosstalk in the postmenopausal: from dysbiosis mechanisms to precision interventions. | Front Microbiol | 2026 | 41800413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/151306/papers?page=6